Glioblastoma has remained one of the toughest cancers to treat, resisting even the latest advances in immunotherapy. But new research from Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, suggests a way forward: suppressing a protein called ZNF638 triggers an antiviral immune response, making immune checkpoint inhibitors more effective.
A post-treatment blood test could inform future cancer therapy decisions
In the continuing evolution of personalized medicine, a new Yale study has found evidence to support the value of a tool that measures the presence of cancer-derived molecules in the blood of patients with lung cancer years after their treatment.
Bridging nature and nurture: Study reveals brain’s flexible foundation from birth
For years, researchers have debated how our brains consistently develop areas specialized for recognizing faces, objects, words, and places, despite individuals having vastly different life experiences.
Small incentives drive lasting seatbelt habits
We’ve all heard “Click It, or Ticket” as a reminder to buckle up in the car, but “Click It and Win It!” appears to be an effective approach for sustaining consistent seatbelt use among drivers. When drivers were promised a share of $125 weekly prize money for maintaining perfect seatbelt use streaks, they established good, long-lasting habits.
Report encourages tax on sugar and salt in food to improve health in UK
The UK government should extend its sugar tax beyond soft drinks to cover all types of foods, according to a major new report published today (17 March).
Alcohol and cancer risk: What we know
Most people know about the connection between cigarettes and cancer risk, but does drinking cause cancer? It’s something rarely discussed, despite years of evidence that alcohol increases cancer risk.
How does education affect Alzheimer’s and dementia risk? It’s about more than degree attainment
Education has long been associated with reduced risk of Alzheimer’s disease and related dementias, but a new study reveals that this protection extends far beyond diplomas and degrees. Co-led by researchers at The University of Texas at Austin, the University of Minnesota, the University of Wisconsin-Madison and Columbia University, the study investigated how high school contexts, opportunities and outcomes shape midlife cognition even among people with the same completed degrees.
As measles outbreak spreads, pediatric infectious disease expert discusses vaccine safety
Christina Hermos, MD’03, MMSc, hasn’t seen a case of measles since she was doing a fellowship two decades ago. And that was a rare case, involving a child who had arrived from overseas.
AstraZeneca buys cell therapy firm EsoBiotec for $1bn
British pharmaceutical giant AstraZeneca on Monday announced an agreement to buy Belgian cell therapy firm EsoBiotec for up to $1 billion, expanding its treatments for cancer.
Virtual reality platform offers new hope for speech anxiety sufferers
The fear of public speaking is widely cited as being the most common fear. Furthermore, there is evidence to suggest that the prevalence of social anxiety and a fear of public speaking are both on the rise. This is concerning when one considers the range of known subsequent negative impacts on mental health, physical health, academic attainment, and career progression.